Skip to main content
NCBI home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1992 Jun;50(6):1203–1210.

A molecular defect in human protoporphyria.

D A Brenner 1, J M Didier 1, F Frasier 1, S R Christensen 1, G A Evans 1, H A Dailey 1
PMCID: PMC1682545  PMID: 1376018

Abstract

Protoporphyria is generally an autosomal dominant disease that is characterized clinically by photosensitivity and hepatobiliary disease and that is characterized biochemically by elevated protoporphyrin levels. The enzymatic activity of ferrochelatase, which catalyzes the last step in the heme biosynthetic pathway, is deficient in all tissues of patients with protoporphyria. In this study, sequencing of ferrochelatase cDNAs from a patient with protoporphyria revealed a single point mutation in the cDNAs resulting in the conversion of a Phe(TTC) to a Ser(TCC) in the carboxy-terminal end of the protein, F417S. Further, the human ferrochelatase gene was mapped to chromosome 18q21.3 by chromosomal in situ suppression hybridization. Finally, expression of recombinant ferrochelatase in Escherichia coli demonstrated a marked deficiency in activity of the mutant ferrochelatase protein and of mouse-human mutant ferrochelatase chimeric proteins. Therefore, a point mutation in the coding region of the ferrochelatase gene is the genetic defect in some patients with protoporphyria.

Full text

PDF
1203

Images in this article

1205Figure 1
on p.1205
1205Figure 2
on p.1205
1207Figure 3
on p.1207

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amann E., Ochs B., Abel K. J. Tightly regulated tac promoter vectors useful for the expression of unfused and fused proteins in Escherichia coli. Gene. 1988 Sep 30;69(2):301–315. doi: 10.1016/0378-1119(88)90440-4. [DOI] [PubMed] [Google Scholar]
  2. Bloomer J. R., Bonkowsky H. L., Ebert P. S., Mahoney M. J. Inheritance in protoporphyria. Comparison of haem synthetase activity in skin fibroblasts with clinical features. Lancet. 1976 Jul 31;2(7979):226–228. doi: 10.1016/s0140-6736(76)91027-8. [DOI] [PubMed] [Google Scholar]
  3. Bloomer J. R., Phillips M. J., Davidson D. L., Klatskin G., Bloomer Hepatic disease in erythropoietic protoporphyria. Am J Med. 1975 Jun;58(6):869–882. doi: 10.1016/0002-9343(75)90644-0. [DOI] [PubMed] [Google Scholar]
  4. Bloomer J. R., Weimer M. K., Bossenmaier I. C., Snover D. C., Payne W. D., Ascher N. L. Liver transplantation in a patient with protoporphyria. Gastroenterology. 1989 Jul;97(1):188–194. doi: 10.1016/0016-5085(89)91434-0. [DOI] [PubMed] [Google Scholar]
  5. Bonkowsky H. L., Bloomer J. R., Ebert P. S., Mahoney M. J. Heme synthetase deficiency in human protoporphyria. Demonstration of the defect in liver and cultured skin fibroblasts. J Clin Invest. 1975 Nov;56(5):1139–1148. doi: 10.1172/JCI108189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bottomley S. S., Tanaka M., Everett M. A. Diminished erythroid ferrochelatase activity in protoporphyria. J Lab Clin Med. 1975 Jul;86(1):126–131. [PubMed] [Google Scholar]
  7. Brenner D. A., Chojkier M. Acetaldehyde increases collagen gene transcription in cultured human fibroblasts. J Biol Chem. 1987 Dec 25;262(36):17690–17695. [PubMed] [Google Scholar]
  8. Brenner D. A., Frasier F. Cloning of murine ferrochelatase. Proc Natl Acad Sci U S A. 1991 Feb 1;88(3):849–853. doi: 10.1073/pnas.88.3.849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  10. Cánepa E. T., Llambías E. B. Purification and characterization of ferro- and cobalto-chelatases. Biochem Cell Biol. 1988 Jan;66(1):32–39. doi: 10.1139/o88-005. [DOI] [PubMed] [Google Scholar]
  11. Dailey H. A. Purification and characterization of bacterial ferrochelatase. Methods Enzymol. 1986;123:408–415. doi: 10.1016/s0076-6879(86)23050-5. [DOI] [PubMed] [Google Scholar]
  12. Evans G. A., Wahl G. M. Cosmid vectors for genomic walking and rapid restriction mapping. Methods Enzymol. 1987;152:604–610. doi: 10.1016/0076-6879(87)52068-7. [DOI] [PubMed] [Google Scholar]
  13. Grissmer S., Dethlefs B., Wasmuth J. J., Goldin A. L., Gutman G. A., Cahalan M. D., Chandy K. G. Expression and chromosomal localization of a lymphocyte K+ channel gene. Proc Natl Acad Sci U S A. 1990 Dec;87(23):9411–9415. doi: 10.1073/pnas.87.23.9411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gubler U., Hoffman B. J. A simple and very efficient method for generating cDNA libraries. Gene. 1983 Nov;25(2-3):263–269. doi: 10.1016/0378-1119(83)90230-5. [DOI] [PubMed] [Google Scholar]
  15. Hattori M., Sakaki Y. Dideoxy sequencing method using denatured plasmid templates. Anal Biochem. 1986 Feb 1;152(2):232–238. doi: 10.1016/0003-2697(86)90403-3. [DOI] [PubMed] [Google Scholar]
  16. Herbert A., Corbin D., Williams A., Thompson D., Buckels J., Elias E. Erythropoietic protoporphyria: unusual skin and neurological problems after liver transplantation. Gastroenterology. 1991 Jun;100(6):1753–1757. doi: 10.1016/0016-5085(91)90680-j. [DOI] [PubMed] [Google Scholar]
  17. Karr S. R., Dailey H. A. The synthesis of murine ferrochelatase in vitro and in vivo. Biochem J. 1988 Sep 15;254(3):799–803. doi: 10.1042/bj2540799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Labbe-Bois R. The ferrochelatase from Saccharomyces cerevisiae. Sequence, disruption, and expression of its structural gene HEM15. J Biol Chem. 1990 May 5;265(13):7278–7283. [PubMed] [Google Scholar]
  19. Lamoril J., Boulechfar S., de Verneuil H., Grandchamp B., Nordmann Y., Deybach J. C. Human erythropoietic protoporphyria: two point mutations in the ferrochelatase gene. Biochem Biophys Res Commun. 1991 Dec 16;181(2):594–599. doi: 10.1016/0006-291x(91)91231-z. [DOI] [PubMed] [Google Scholar]
  20. Lichter P., Tang C. J., Call K., Hermanson G., Evans G. A., Housman D., Ward D. C. High-resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. Science. 1990 Jan 5;247(4938):64–69. doi: 10.1126/science.2294592. [DOI] [PubMed] [Google Scholar]
  21. Nakahashi Y., Taketani S., Sameshima Y., Tokunaga R. Characterization of ferrochelatase in kidney and erythroleukemia cells. Biochim Biophys Acta. 1990 Mar 1;1037(3):321–327. doi: 10.1016/0167-4838(90)90032-b. [DOI] [PubMed] [Google Scholar]
  22. Naylor E. W., Murphey W. H., Domoszlai E. I., Guthrie R. Erythropoietic protoporphyria, heterozygous cystinuria, and reduced peptidase A activity in a patient with 46,XX/46,XX,18q--mosaicism. J Med Genet. 1978 Apr;15(2):157–160. doi: 10.1136/jmg.15.2.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Norris P. G., Nunn A. V., Hawk J. L., Cox T. M. Genetic heterogeneity in erythropoietic protoporphyria: a study of the enzymatic defect in nine affected families. J Invest Dermatol. 1990 Sep;95(3):260–263. doi: 10.1111/1523-1747.ep12484876. [DOI] [PubMed] [Google Scholar]
  24. Rademakers L. H., Cleton M. I., Kooijman C., Baart de la Faille H., van Hattum J. Early involvement of hepatic parenchymal cells in erythrohepatic protoporphyria? An ultrastructural study of patients with and without overt liver disease and the effect of chenodeoxycholic acid treatment. Hepatology. 1990 Mar;11(3):449–457. doi: 10.1002/hep.1840110316. [DOI] [PubMed] [Google Scholar]
  25. Saiki R. K., Gelfand D. H., Stoffel S., Scharf S. J., Higuchi R., Horn G. T., Mullis K. B., Erlich H. A. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988 Jan 29;239(4839):487–491. doi: 10.1126/science.2448875. [DOI] [PubMed] [Google Scholar]
  26. Straka J. G., Bloomer J. R., Kempner E. S. The functional size of ferrochelatase determined in situ by radiation inactivation. J Biol Chem. 1991 Dec 25;266(36):24637–24641. [PubMed] [Google Scholar]
  27. Straka J. G., Hill H. D., Krikava J. M., Kools A. M., Bloomer J. R. Immunochemical studies of ferrochelatase protein: characterization of the normal and mutant protein in bovine and human protoporphyria. Am J Hum Genet. 1991 Jan;48(1):72–78. [PMC free article] [PubMed] [Google Scholar]
  28. Taketani S., Nakahashi Y., Osumi T., Tokunaga R. Molecular cloning, sequencing, and expression of mouse ferrochelatase. J Biol Chem. 1990 Nov 15;265(32):19377–19380. [PubMed] [Google Scholar]
  29. Taketani S., Tokunaga R. Rat liver ferrochelatase. Purification, properties, and stimulation by fatty acids. J Biol Chem. 1981 Dec 25;256(24):12748–12753. [PubMed] [Google Scholar]
  30. Went L. N., Klasen E. C. Genetic aspects of erythropoietic protoporphyria. Ann Hum Genet. 1984 May;48(Pt 2):105–117. doi: 10.1111/j.1469-1809.1984.tb01006.x. [DOI] [PubMed] [Google Scholar]
  31. Whitcombe D. M., Carter N. P., Albertson D. G., Smith S. J., Rhodes D. A., Cox T. M. Assignment of the human ferrochelatase gene (FECH) and a locus for protoporphyria to chromosome 18q22. Genomics. 1991 Dec;11(4):1152–1154. doi: 10.1016/0888-7543(91)90044-f. [DOI] [PubMed] [Google Scholar]
  32. de Goeij A. F., Christianse K., van Steveninck J. Decreased haem synthetase activity in blood cells of patients with erythropoietic protoporphyria. Eur J Clin Invest. 1975 Sep 12;5(5):397–400. doi: 10.1111/j.1365-2362.1975.tb00470.x. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES